Given that ALS is characterized by systemic inflammation and metabolic dysregulation, it is plausible that ABCA1 upregulation represents a compensatory mechanism to counteract ongoing inflammatory and metabolic stress. Here, ABCA1 is linked to amyotrophic lateral sclerosis.